Literature DB >> 10158916

Theory and methods of economic evaluation of health care.

M Johannesson1.   

Abstract

Mesh:

Year:  1996        PMID: 10158916

Source DB:  PubMed          Journal:  Dev Health Econ Public Policy        ISSN: 0927-4987


× No keyword cloud information.
  24 in total

1.  Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in australia (1991 to 1996).

Authors:  B George; A Harris; A Mitchell
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 2.  On individual preferences and aggregation in economic evaluation in healthcare.

Authors:  B Liljas; B Lindgren
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

3.  Benefit-cost analysis of addiction treatment: methodological guidelines and empirical application using the DATCAP and ASI.

Authors:  Michael T French; Helena J Salomé; Jody L Sindelar; A Thomas McLellan
Journal:  Health Serv Res       Date:  2002-04       Impact factor: 3.402

Review 4.  Willingness to pay as a measure of health benefits.

Authors:  M V Bala; J A Mauskopf; L L Wood
Journal:  Pharmacoeconomics       Date:  1999-01       Impact factor: 4.981

Review 5.  Theoretical arguments for the discounting of health consequences: where do we go from here?

Authors:  Angelina Lazaro
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

6.  The contingency of contingent valuation. How much are people willing to pay against Alzheimer's disease?

Authors:  Sandra Nocera; Dario Bonato; Harry Telser
Journal:  Int J Health Care Finance Econ       Date:  2002-09

Review 7.  Cost of lung cancer: a methodological review.

Authors:  Laurent Molinier; Christophe Combescure; Cristos Chouaïd; Jean-Pierre Daurès; Bruno Housset; Didier Fabre; Alain Grand; Alain Vergnenègre
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 8.  Therapeutic options for the prevention and treatment of postoperative nausea and vomiting: a pharmacoeconomic review.

Authors:  Jean Lachaine
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 9.  Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches.

Authors:  Sun-Young Kim; Sue J Goldie
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

10.  Cost-of-illness studies: a guide to critical evaluation.

Authors:  Allison Larg; John R Moss
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.